These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9663359

  • 21. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 23. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
    Nathan RA, Bleecker ER, Kalberg C, Fluticasone Propionate Study Group.
    Am J Med; 2001 Aug 15; 111(3):195-202. PubMed ID: 11530030
    [Abstract] [Full Text] [Related]

  • 24. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov 15; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 25. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
    J Asthma; 2007 Nov 15; 44(6):437-41. PubMed ID: 17654129
    [Abstract] [Full Text] [Related]

  • 26. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 15; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jun 15; 96(6):808-18. PubMed ID: 16802768
    [Abstract] [Full Text] [Related]

  • 28. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ, Clark DJ, McFarlane LC.
    Thorax; 1997 Aug 15; 52(8):686-9. PubMed ID: 9337826
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
    Arch Dis Child; 1993 Aug 15; 69(2):206-11. PubMed ID: 8215522
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.
    Lawrence M, Wolfe J, Webb DR, Chervinsky P, Kellerman D, Schaumberg JP, Shah T.
    Am J Respir Crit Care Med; 1997 Sep 15; 156(3 Pt 1):744-51. PubMed ID: 9309988
    [Abstract] [Full Text] [Related]

  • 31. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
    Van den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI.
    Pediatr Pulmonol; 2000 Aug 15; 30(2):97-105. PubMed ID: 10922131
    [Abstract] [Full Text] [Related]

  • 32. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
    Eur Respir J; 1996 Nov 15; 9(11):2263-72. PubMed ID: 8947070
    [Abstract] [Full Text] [Related]

  • 33. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W, Wolfe J, Storms W, Srebro S, Edwards L, Johnson M, Bowers BW, Rogenes PR, Rickard K.
    J Fam Pract; 2001 Jul 15; 50(7):595-602. PubMed ID: 11485708
    [Abstract] [Full Text] [Related]

  • 34. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
    Bateman ED, Silins V, Bogolubov M.
    Respir Med; 2001 Feb 15; 95(2):136-46. PubMed ID: 11217910
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S, Engelstätter R, Weber HJ, Hirsch S, Barkai L, Emeryk A, Weber H, Vermeulen J.
    Pulm Pharmacol Ther; 2009 Jun 15; 22(3):214-20. PubMed ID: 19141327
    [Abstract] [Full Text] [Related]

  • 36. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 15; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 37. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW, Micheletto C, Tognella S, Trevisan F, Guerriero M.
    Eur Ann Allergy Clin Immunol; 2006 May 15; 38(5):153-7. PubMed ID: 17058847
    [Abstract] [Full Text] [Related]

  • 38. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma.
    Kuna P, Joubert JR, Greefhorst LA, Magnussen H.
    Clin Ther; 2003 Aug 15; 25(8):2182-97. PubMed ID: 14512127
    [Abstract] [Full Text] [Related]

  • 39. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
    Respir Med; 2000 Jun 15; 94 Suppl B():S29-34. PubMed ID: 10919683
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
    Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S, Zhang P.
    J Pediatr; 1999 Apr 15; 134(4):422-7. PubMed ID: 10190915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.